Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 168

1.

The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis.

Alpizar-Rodriguez D, Brulhart L, Mueller RB, Möller B, Dudler J, Ciurea A, Walker UA, Von Mühlenen I, Kyburz D, Zufferey P, Mahler M, Bas S, Gascon D, Lamacchia C, Roux-Lombard P, Lauper K, Nissen MJ, Courvoisier DS, Gabay C, Finckh A.

Clin Rheumatol. 2017 Mar;36(3):677-682. doi: 10.1007/s10067-017-3547-3. Epub 2017 Jan 21.

PMID:
28110385
2.

Pyoderma Gangrenosum and Erythema Nodosum Revealing Takayasu's Arteritis.

Loetscher J, Fistarol S, Walker UA.

Case Rep Dermatol. 2016 Dec 7;8(3):354-357. doi: 10.1159/000452829. eCollection 2016 Sep-Dec.

3.

Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study.

Jaeger VK, Wirz EG, Allanore Y, Rossbach P, Riemekasten G, Hachulla E, Distler O, Airò P, Carreira PE, Balbir Gurman A, Tikly M, Vettori S, Damjanov N, Müller-Ladner U, Distler JH, Li M, Walker UA; EUSTAR co-authors..

PLoS One. 2016 Oct 5;11(10):e0163894. doi: 10.1371/journal.pone.0163894. eCollection 2016.

4.

The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index.

Valentini G, Iudici M, Walker UA, Jaeger VK, Baron M, Carreira P, Czirják L, Denton CP, Distler O, Hachulla E, Herrick AL, Kowal-Bielecka O, Pope J, Müller-Ladner U, Riemekasten G, Avouac J, Frerix M, Jordan S, Minier T, Siegert E, Ong VH, Vettori S, Allanore Y.

Ann Rheum Dis. 2017 Jan;76(1):270-276. doi: 10.1136/annrheumdis-2016-209768. Epub 2016 Sep 12.

PMID:
27621285
5.

Erectile Dysfunction in Systemic Sclerosis.

Jaeger VK, Walker UA.

Curr Rheumatol Rep. 2016 Aug;18(8):49. doi: 10.1007/s11926-016-0597-5. Review.

PMID:
27402106
6.

Immunomodulation of rheumatologic disorders with non-biologic disease modifying antirheumtic drugs.

Walker UA.

Semin Hematol. 2016 Apr;53 Suppl 1:S58-60. doi: 10.1053/j.seminhematol.2016.04.017. Epub 2016 Apr 7.

PMID:
27312168
7.

Brief Report: Severe Inflammation Following Vaccination Against Streptococcus pneumoniae in Patients With Cryopyrin-Associated Periodic Syndromes.

Walker UA, Hoffman HM, Williams R, Kuemmerle-Deschner J, Hawkins PN.

Arthritis Rheumatol. 2016 Feb;68(2):516-20. doi: 10.1002/art.39482.

8.

Role of MRI in diagnosis and management of idiopathic inflammatory myopathies.

Maurer B, Walker UA.

Curr Rheumatol Rep. 2015 Nov;17(11):67. doi: 10.1007/s11926-015-0544-x. Review.

PMID:
26385754
9.

Autopsy versus clinical findings in patients with systemic sclerosis in a case series from patients of the EUSTAR database.

Sandmeier B, Jäger VK, Nagy G, Carreira PE, Tzankov A, Widuchowska M, Antic M, Distler O, Reichert H, Distler JH, Walker UA, Hügle T.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S75-9. Epub 2015 Sep 1.

PMID:
26339891
10.

Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis.

Walker UA, Jaeger VK, Chatzidionysiou K, Hetland ML, Hauge EM, Pavelka K, Nordström DC, Canhão H, Tomšič M, van Vollenhoven R, Gabay C.

Rheumatology (Oxford). 2016 Feb;55(2):230-6. doi: 10.1093/rheumatology/kev297. Epub 2015 Aug 27.

PMID:
26316581
11.

An observational cohort study of patients with newly diagnosed digital ulcer disease secondary to systemic sclerosis registered in the EUSTAR database.

Brand M, Hollaender R, Rosenberg D, Scott M, Hunsche E, Tyndall A, Denaro V, Carreira P, Varju C, Gabrielli B, Zingarelli S, Caramaschi P, Simic-Pasalic K, Müller-Ladner U, Vasile M, Mihai C, Rosato E, Vacca A, Zenone T, Mohamed WA, Ancuta C, Zampogna G, Rednic S, Jabaar N, Belloli L, Pozzi MR, Foti R, Walker UA; EUSTAR Co-Investigators..

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S47-54. Epub 2015 Aug 5.

PMID:
26243652
12.

Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database.

Wirz EG, Jaeger VK, Allanore Y, Riemekasten G, Hachulla E, Distler O, Airò P, Carreira PE, Tikly M, Vettori S, Balbir Gurman A, Damjanov N, Müller-Ladner U, Distler J, Li M, Häusermann P, Walker UA; EUSTAR coauthors..

Ann Rheum Dis. 2016 Jul;75(7):1285-92. doi: 10.1136/annrheumdis-2015-207271. Epub 2015 Jul 31.

PMID:
26232495
13.

The ultrasound compression sign to diagnose temporal giant cell arteritis shows an excellent interobserver agreement.

Aschwanden M, Imfeld S, Staub D, Baldi T, Walker UA, Berger CT, Hess C, Daikeler T.

Clin Exp Rheumatol. 2015 Mar-Apr;33(2 Suppl 89):S-113-5. Epub 2015 May 26.

PMID:
26016760
14.

Magnetic Resonance Imaging-Confirmed Pleuritis in Systemic Lupus Erythematosus-Associated Shrinking Lung Syndrome.

Nemec M, Pradella M, Jahn K, Tamm M, Walker UA.

Arthritis Rheumatol. 2015 Jul;67(7):1880. doi: 10.1002/art.39141. No abstract available.

15.

[Common German language nomenclature for systemic sclerosis].

Aringer M, Müller-Ladner U, Burkhardt H, Distler JH, Distler O, Graninger WB, Günther C, Hunzelmann N, Kiener H, Sticherling M, Sunderkötter C, Walker UA, Riemekasten G.

Z Rheumatol. 2015 Mar;74(2):100-3. doi: 10.1007/s00393-014-1550-5. German.

PMID:
25805510
16.

Quantitative dynamic contrast-enhanced ultrasound for the functional evaluation of the skeletal muscle microcirculation in systemic sclerosis.

Partovi S, Kaspar M, Aschwanden M, Robbin MR, Bilecen D, Walker UA, Staub D.

Clin Hemorheol Microcirc. 2016;62(1):35-44. doi: 10.3233/CH-151929.

PMID:
25757455
17.

Digital ulcers predict a worse disease course in patients with systemic sclerosis.

Mihai C, Landewé R, van der Heijde D, Walker UA, Constantin PI, Gherghe AM, Ionescu R, Rednic S, Allanore Y, Avouac J, Czirják L, Hachulla E, Riemekasten G, Cozzi F, Airò P, Cutolo M, Mueller-Ladner U, Matucci-Cerinic M; EUSTAR co-authors..

Ann Rheum Dis. 2016 Apr;75(4):681-6. doi: 10.1136/annrheumdis-2014-205897. Epub 2015 Feb 16.

PMID:
25688073
18.

Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population.

Hachulla E, Clerson P, Airò P, Cuomo G, Allanore Y, Caramaschi P, Rosato E, Carreira PE, Riccieri V, Sarraco M, Denton CP, Riemekasten G, Pozzi MR, Zeni S, Mihai CM, Ullman S, Distler O, Rednic S, Smith V, Walker UA, Matucci-Cerinic M, Müller-Ladner U, Launay D; EUSTAR co-workers..

Rheumatology (Oxford). 2015 Jul;54(7):1262-9. doi: 10.1093/rheumatology/keu450. Epub 2015 Jan 17.

19.

A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study.

Elhai M, Avouac J, Walker UA, Matucci-Cerinic M, Riemekasten G, Airò P, Hachulla E, Valentini G, Carreira PE, Cozzi F, Balbir Gurman A, Braun-Moscovici Y, Damjanov N, Ananieva LP, Scorza R, Jimenez S, Busquets J, Li M, Müller-Ladner U, Kahan A, Distler O, Allanore Y; EUSTAR co-authors..

Ann Rheum Dis. 2016 Jan;75(1):163-9. doi: 10.1136/annrheumdis-2014-206386. Epub 2014 Oct 23.

PMID:
25342760
20.

Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study.

Avouac J, Walker UA, Hachulla E, Riemekasten G, Cuomo G, Carreira PE, Caramaschi P, Ananieva LP, Matucci-Cerinic M, Czirjak L, Denton C, Ladner UM, Allanore Y; EUSTAR collaborators*.; EUSTAR collaborators..

Ann Rheum Dis. 2016 Jan;75(1):103-9. doi: 10.1136/annrheumdis-2014-205295. Epub 2014 Aug 27.

PMID:
25165035

Supplemental Content

Loading ...
Support Center